Navigation Links
Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms
Date:8/21/2014

BURLINGTON, Mass., Aug. 21, 2014 /PRNewswire/ -- Decision Resources Group finds that, for the treatment of COPD,  physicians in Brazil and Mexico manage to follow clinical guidelines and commonly prescribe long-acting beta-agonist (LABA)- and long-acting muscarinic antagonist (LAMA)- containing regimens, although they do so within current severe cost/coverage constraints. Therefore, new brands of LABA/LAMA fixed-dose combinations (FDCs) that are expected to launch in these countries—which will considerably expand the chronic obstructive pulmonary disease (COPD) market—will compete with well-established marketed therapies, especially the twice-daily LABA/ inhaled corticosteroids (ICS) FDCs. New LABA/LAMA FDCs will also compete with recently launched once-daily Relvar/Relvare (GlaxoSmithKline/Theravance). According to payers, improvements in dosing and delivery of new FDCs of current drugs/drug classes are important but may not be enough to justify a premium price over comparator drugs or its separate components.

Other key findings from the Emerging Markets Physician and Payer Forum report entitled Positioning of Current and Emerging Agents for COPD: Physician and Payer Perspectives on the Prescribing and Patient Access Landscape in Brazil and Mexico include:

  • Factors impacting formulary inclusion: In Brazil, CONITEC (Brazil's HTA agency) is restricting the incorporation of new COPD drugs in the coverage offered by the public healthcare system. Demonstration of superior comparative clinical and economic benefit, preferably using local data, is crucial to formulary inclusion.
  • Exclusion of key agents: In Mexico, although th
    '/>"/>

SOURCE Decision Resources Group
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema
2. Globavir Seeking Approval and Launch of Novel Ebola Treatment Before Year End
3. The Impact of Genericization in the Unipolar Depression Market Will be Tempered by the Continued Uptake of Novel Antidepressants and Antipsychotics
4. Charleston Laboratories and Daiichi Sankyo Announce Collaboration to Develop and Commercialize Novel, Fixed-Dose Combination Hydrocodone Products for Pain and Opioid-Induced Nausea and Vomiting (OINV) in the US
5. FDA Grants Fast Track Designation to CTI BioPharmas Pacritinib, a Novel JAK2 Inhibitor for the Treatment of Myelofibrosis
6. Daiichi Sankyo and Charleston Laboratories Announce Collaboration to Develop and Commercialize Novel, Fixed-Dose Combination Hydrocodone Products for Pain and Opioid-Induced Nausea and Vomiting (OINV) in the US
7. Glide Pharma Takes Exclusive Worldwide Rights to Novel Diagnostic Technology for Prostate Cancer
8. Particle Sciences and Eyeon Therapeutics Receive Patent on Novel Dry Eye Technology
9. Glide Pharma Completes Successful Proof-of-Concept Study with Novel Solid Dose Formulation of Octreotide
10. Synthetic Biologics Academic Collaborator to Present Novel Monoclonal Antibody Combination for Treating Whooping Cough (Pertussis) at Gordon Research Conference
11. ViaCyte Files Investigational New Drug Application and Device Master File with FDA for Novel Cell Replacement Therapy Product Candidate Designed to Treat Patients with Type 1 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... DUBLIN , May 29, 2015 ... the addition of the "Global A Dialyzer ... 2014" report to their offering. ... Reprocessor ) Industry Report 2014 is a professional ... the A dialyzer reprocessing machine industry. The ...
(Date:6/1/2015)... N.Y. , June 1, 2015 ... HRTX ) today announced positive, top-line results ... MAGIC evaluated the efficacy and safety of the ... SUSTOL ® (granisetron injection, extended release) as ... (IV) neurokinin-1 (NK 1 ) receptor antagonist fosaprepitant ...
(Date:6/1/2015)... CLEVELAND , June 1, 2015 Researchers ... and Case Western Reserve University School of Medicine will ... evaluating a potential novel combination treatment for cancer patients ... gene mutations in small cell lung cancer (SCLC), at ... (ASCO) Annual Meeting in Chicago . ...
Breaking Medicine Technology:Global A Dialyzer Reprocessing Machine (A Dialyzer Reprocessor) Industry Report 2014 - Development Trends Forecasts to 2020 2Global A Dialyzer Reprocessing Machine (A Dialyzer Reprocessor) Industry Report 2014 - Development Trends Forecasts to 2020 3New cancer therapy study results - MAGIC Trial 2UH Case Medical Center Experts to Present Data at 51st ASCO Annual Meeting 2UH Case Medical Center Experts to Present Data at 51st ASCO Annual Meeting 3
... New results from an observational substudy from ... Association (AHA) Scientific Sessions annual meeting showed that ... artery bypass graft surgery (CABG) had a reduced ... Plavix® (clopidogrel) (2.3 percent versus 8.7 percent respectively, ...
... one of the world,s leading research and advisory firms ... the launch of several novel agents, the hepatitis C ... approximately $2 billion in 2009 to nearly $7.5 billion ... Spain, the United Kingdom and Japan. Thereafter, the market ...
Cached Medicine Technology:Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 2Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 3Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 4Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 5Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 6The Hepatitis C Virus Drug Market Will Nearly Triple by 2014 but, Thereafter, the Market Will Decline Substantially Through 2019 Due to Decreasing Disease Prevalence and the High Efficacy of New Treatments 2The Hepatitis C Virus Drug Market Will Nearly Triple by 2014 but, Thereafter, the Market Will Decline Substantially Through 2019 Due to Decreasing Disease Prevalence and the High Efficacy of New Treatments 3
(Date:6/2/2015)... Date: Thursday, June 4, 2015 , Time: 2 ... Broad Street, 4th floor, Philadelphia, Pa 19107 , ... will visit Philadelphia City Council to urge city leaders ... C in Philadelphia’s at-risk populations. , Foundation leaders and ... B United Philadelphia (HBUP), will join Hepatitis C Allies ...
(Date:6/2/2015)... New York, NY (PRWEB) June 02, 2015 ... leader in minimally invasive spine surgery with three locations ... office in New York City. The new facility is ... York, N.Y. 10028. Telephone consultations and appointments can be ... founder and chief surgeon at Atlantic Spine Center, has ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Pacifica ... fund set up by current and former students to ... beloved faculty member from 2002 until his death in ... intelligence, and depth of feeling, as well as his ... His capacities as an analyst, teacher, and writer were ...
(Date:6/1/2015)... The National Association of Professional Women ... 2015-2016 inductee into its VIP Woman of the Year ... leadership in business. NAPW is the nation’s leading networking ... members and over 200 operating Local Chapters. , “I’m ... NAPW President Star Jones. “Job satisfaction is essential for ...
(Date:6/1/2015)... 02, 2015 The National Association ... as a 2015-2016 inductee into the NAPW VIP ... with this prestigious distinction for leadership in academics. With ... Chapters, NAPW is the nation’s leading networking organization exclusively ... with this important distinction,” said NAPW President Star Jones. ...
Breaking Medicine News(10 mins):Health News:Hepatitis B Foundation to Urge Philadelphia Leaders to Make Viral Hepatitis Prevention a Local Priority 2Health News:Renowned Endoscopic Spine Surgeon Dr. Kaixuan Liu Announces Opening of Park Avenue Office 2Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 2Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 3Health News:National Association of Professional Women Inducts Miriam Wirski, Holistic Life Coach, Into its VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Marcia Ditmyer, Vice President of Academy for Academic Leadership, Into its VIP Professional Woman of the Year Circle 2
... , INDIANAPOLIS, Sept. 9 WellPoint, Inc. (NYSE: ... Medicare Advantage and 2010 Medicare Part D health benefit plans effective Oct. ... Medicare Part D health benefit plans on Nov. 15, 2009 for the ... Medicare and Medicaid Services (CMS) has determined that WellPoint has corrected deficiencies ...
... approval of second HPV vaccine, Cervarix, to prevent cervical cancer ... recommended Wednesday that use of the vaccine Gardasil, already administered ... help prevent genital warts in young males. , A U.S. ... expanded use of the vaccine for males 9 to 26. ...
... , WASHINGTON, Sept. 9 San Francisco Mayor ... tonight for the President,s historic speech on healthcare reform before a ... As Co-Chair of the U.S. Conference of Mayors Healthcare ... mayors around the country to urge Congress to pass comprehensive health ...
... dormant, common virus that crosses over into brain , WEDNESDAY, ... of the reason why Tysabri, a drug used to treat ... but potentially deadly brain disease in some patients. , The ... its slumber, allowing it to cross into the brain. , ...
... Sept. 9 Stryker Corporation (NYSE: SYK ) announced ... 20, 2009, at 4:30 p.m., Eastern Time, to discuss the Company,s ... an operational update. Operating results for the quarter ended September 30, ... , To participate in the conference call dial 800-706-7745 ...
... , PITTSBURGH, Sept. 9 The California ... host filmmaker Michael Moore at a special reception Monday night, along ... A Love Story" at the AFL-CIO national convention in Pittsburgh. , ... will outline the ongoing campaign for single payer healthcare reform by ...
Cached Medicine News:Health News:Statement on WellPoint's Re-Entry into Medicare Market 2Health News:FDA Panel Backs Giving HPV Vaccine Gardasil to Young Males 2Health News:FDA Panel Backs Giving HPV Vaccine Gardasil to Young Males 3Health News:FDA Panel Backs Giving HPV Vaccine Gardasil to Young Males 4Health News:Mayor Gavin Newsom to Be President Obama's Guest for Healthcare Reform Speech to the Nation 2Health News:Scientists Find Clue to Dangerous Side Effect of MS Drug 2Health News:Scientists Find Clue to Dangerous Side Effect of MS Drug 3Health News:Stryker To Host Conference Call on October 20, 2009 2Health News:Nurses, AFL-CIO Unions to Host Michael Moore and Special Screening of New Film at AFL-CIO Convention 2
... German Craftsmanship have produced ... in the world. Ocutek® ... to you! Only holders ... certificate, which requires and ...
... Centuries of German Craftsmanship ... surgical instrumentation in the ... them available to you! ... coveted Meisterbrief certificate, which ...
... Centuries of German Craftsmanship ... surgical instrumentation in the ... them available to you! ... coveted Meisterbrief certificate, which ...
... Centuries of German Craftsmanship ... surgical instrumentation in the ... them available to you! ... coveted Meisterbrief certificate, which ...
Medicine Products: